Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInventory AverageInvested CapitalMarket Capitalization

RedHill Biopharma (RDHL) Operating Margin: 2009-2024

Historic Operating Margin for RedHill Biopharma (RDHL) over the last 16 years, with Dec 2024 value amounting to -181.69%.

  • RedHill Biopharma's Operating Margin rose 322408.00% to 2,992.87% in Q2 2023 from the same period last year, while for Jun 2023 it was -122.98%, marking a year-over-year increase of 7662.00%. This contributed to the annual value of -181.69% for FY2024, which is 37513.00% down from last year.
  • According to the latest figures from FY2024, RedHill Biopharma's Operating Margin is -181.69%, which was down 193.92% from 193.45% recorded in FY2023.
  • In the past 5 years, RedHill Biopharma's Operating Margin ranged from a high of 193.45% in FY2023 and a low of -181.69% during FY2024.
  • For the 3-year period, RedHill Biopharma's Operating Margin averaged around -19.19%, with its median value being -69.33% (2022).
  • In the last 5 years, RedHill Biopharma's Operating Margin plummeted by 58,776bps in 2020 and then soared by 26,277bps in 2023.
  • Yearly analysis of 5 years shows RedHill Biopharma's Operating Margin stood at 98.95% in 2020, then crashed by 19,356bps to -94.61% in 2021, then soared by 2,528bps to -69.33% in 2022, then skyrocketed by 26,277bps to 193.45% in 2023, then crashed by 37,513bps to -181.69% in 2024.